Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-25

FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for COLCRYS (colchicine) filed by Takeda Pharmaceuticals America, expanding or updating the drug's existing approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCRYS (COLCHICINE)

Snippet

SUPPL AP for COLCRYS (COLCHICINE)